Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 25995 | 265 | 32.1 | 55% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 14 | 4 | ORTHOPEDICS//DENTISTRY, ORAL SURGERY & MEDICINE//SPORT SCIENCES | 808941 |
| 32 | 3 | OSTEOPOROSIS//VITAMIN D//OSTEOPOROSIS INTERNATIONAL | 107093 |
| 433 | 2 | HYPERPARATHYROIDISM//PRIMARY HYPERPARATHYROIDISM//SECONDARY HYPERPARATHYROIDISM | 16350 |
| 25995 | 1 | CYTOSOLIC CALCIUM//BETA ISLETS OF THE PANCREAS//CA2 ATPASE UREMIA | 265 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | CYTOSOLIC CALCIUM | authKW | 222486 | 11% | 6% | 30 |
| 2 | BETA ISLETS OF THE PANCREAS | authKW | 115228 | 0% | 100% | 1 |
| 3 | CA2 ATPASE UREMIA | authKW | 115228 | 0% | 100% | 1 |
| 4 | CA2 MG2 DEPENDENT ATP ASE | authKW | 115228 | 0% | 100% | 1 |
| 5 | CA2 MG2 TRANSPORTING ATPASE | authKW | 115228 | 0% | 100% | 1 |
| 6 | CALCIUM ACTIVATED ADENOSINE TRIPHOSPHATASE | authKW | 115228 | 0% | 100% | 1 |
| 7 | CELL DYSFUNCTION IN DIABETES | authKW | 115228 | 0% | 100% | 1 |
| 8 | CONTROL VACCINES SERA | address | 115228 | 0% | 100% | 1 |
| 9 | CYSTOSOLIC CALCIUM | authKW | 115228 | 0% | 100% | 1 |
| 10 | D MYO INOSITOL 4 5 BISPHOSPHATE | authKW | 115228 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Urology & Nephrology | 5680 | 43% | 0% | 113 |
| 2 | Endocrinology & Metabolism | 250 | 13% | 0% | 34 |
| 3 | Medicine, Research & Experimental | 134 | 9% | 0% | 25 |
| 4 | Transplantation | 126 | 5% | 0% | 13 |
| 5 | Physiology | 110 | 8% | 0% | 21 |
| 6 | Medicine, General & Internal | 85 | 10% | 0% | 26 |
| 7 | Engineering, Biomedical | 25 | 3% | 0% | 8 |
| 8 | Pathology | 8 | 2% | 0% | 6 |
| 9 | Rheumatology | 5 | 1% | 0% | 3 |
| 10 | Gastroenterology & Hepatology | 3 | 2% | 0% | 5 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | CONTROL VACCINES SERA | 115228 | 0% | 100% | 1 |
| 2 | DEROY SURG | 115228 | 0% | 100% | 1 |
| 3 | IMMUNO HISTOCOMPATIBILITE | 115228 | 0% | 100% | 1 |
| 4 | INT MED D NEPHROL | 115228 | 0% | 100% | 1 |
| 5 | KECK MED NEPHROL | 115228 | 0% | 100% | 1 |
| 6 | VET ANTICANC | 115228 | 0% | 100% | 1 |
| 7 | YAHATA HIGASHIKU | 115228 | 0% | 100% | 1 |
| 8 | LUDWIG BOLTZMANN CLIN ENDOCRINOL | 57613 | 0% | 50% | 1 |
| 9 | MED NEPHROL 2025 ZONAL AVE | 57613 | 0% | 50% | 1 |
| 10 | SERV IMMUNO HEMATOL | 57613 | 0% | 50% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | MINERAL AND ELECTROLYTE METABOLISM | 22693 | 6% | 1% | 15 |
| 2 | KIDNEY INTERNATIONAL | 12114 | 15% | 0% | 39 |
| 3 | AMERICAN JOURNAL OF NEPHROLOGY | 9115 | 6% | 0% | 16 |
| 4 | CLINICAL NEPHROLOGY | 2325 | 4% | 0% | 10 |
| 5 | AMERICAN JOURNAL OF KIDNEY DISEASES | 1635 | 4% | 0% | 11 |
| 6 | NEPHRON | 1163 | 3% | 0% | 7 |
| 7 | FUNKTIONELLE BIOLOGIE & MEDIZIN | 1150 | 0% | 1% | 1 |
| 8 | JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1006 | 3% | 0% | 8 |
| 9 | JOURNAL OF LABORATORY AND CLINICAL MEDICINE | 711 | 2% | 0% | 5 |
| 10 | PHYSIOLOGICAL CHEMISTRY AND PHYSICS | 696 | 0% | 1% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | MASSRY, SG , SMOGORZEWSKI, M , (1994) MECHANISMS THROUGH WHICH PARATHYROID-HORMONE MEDIATES ITS DELETERIOUS EFFECTS ON ORGAN FUNCTION IN UREMIA.SEMINARS IN NEPHROLOGY. VOL. 14. ISSUE 3. P. 219-231 | 36 | 63% | 103 |
| 2 | GEARA, AS , CASTELLANOS, MR , BASSIL, C , SCHULLER-LEVIS, G , PARK, E , SMITH, M , GOLDMAN, M , ELSAYEGH, S , (2010) EFFECTS OF PARATHYROID HORMONE ON IMMUNE FUNCTION.CLINICAL & DEVELOPMENTAL IMMUNOLOGY. VOL. . ISSUE . P. - | 27 | 52% | 5 |
| 3 | BRO, S , OLGAARD, K , (1997) EFFECTS OF EXCESS PTH ON NONCLASSICAL TARGET ORGANS.AMERICAN JOURNAL OF KIDNEY DISEASES. VOL. 30. ISSUE 5. P. 606-620 | 47 | 37% | 100 |
| 4 | MASSRY, SG , SMOGORZEWSKI, M , (1998) PTH-PTHRP RECEPTOR IN CHRONIC RENAL FAILURE.NEPHROLOGY DIALYSIS TRANSPLANTATION. VOL. 13. ISSUE . P. 50 -57 | 25 | 76% | 7 |
| 5 | ALEXIEWICZ, JM , SMOGORZEWSKI, M , AKMAL, M , MASSRY, SG , (1997) A LONGITUDINAL STUDY ON THE EFFECT OF NIFEDIPINE THERAPY AND ITS DISCONTINUATION ON [CA2+]I AND PROLIFERATION OF B LYMPHOCYTES OF DIALYSIS PATIENTS.AMERICAN JOURNAL OF KIDNEY DISEASES. VOL. 29. ISSUE 2. P. 233-238 | 21 | 84% | 2 |
| 6 | CASTELLANOS, M , JUNG, E , PARK, SY , SCHULLER-LEVIS, G , ODAIMI, M , ELSAYEGH, S , KLEINER, M , ELSOUEIDI, R , SHTAYNBERG, N , PARK, E , (2010) EFFECT OF PARATHYROID HORMONE AND TERIPARATIDE ON IMMUNE FUNCTION OF HUMAN ADHERENT AND NON-ADHERENT LEUKOCYTES.CLINICAL NEPHROLOGY. VOL. 74. ISSUE 2. P. 83 -90 | 18 | 58% | 1 |
| 7 | RITZ, E , STEFANSKI, A , RAMBAUSEK, M , (1995) THE ROLE OF THE PARATHYROID-GLANDS IN THE UREMIC SYNDROME.AMERICAN JOURNAL OF KIDNEY DISEASES. VOL. 26. ISSUE 5. P. 808-813 | 24 | 65% | 26 |
| 8 | MASSRY, SG , (2011) SEQUENCE OF CELLULAR EVENTS IN PANCREATIC ISLETS LEADING TO IMPAIRED INSULIN SECRETION IN CHRONIC KIDNEY DISEASE.JOURNAL OF RENAL NUTRITION. VOL. 21. ISSUE 1. P. 92 -99 | 15 | 65% | 1 |
| 9 | MASSRY, SG , FADDA, GZ , (1993) CHRONIC-RENAL-FAILURE IS A STATE OF CELLULAR CALCIUM TOXICITY.AMERICAN JOURNAL OF KIDNEY DISEASES. VOL. 21. ISSUE 1. P. 81-86 | 22 | 71% | 65 |
| 10 | HORL, WH , HAAGWEBER, M , MAI, B , MASSRY, SG , (1995) VERAPAMIL REVERSES ABNORMAL [CA2+]I AND CARBOHYDRATE-METABOLISM OF PMNL OF DIALYSIS PATIENTS.KIDNEY INTERNATIONAL. VOL. 47. ISSUE 6. P. 1741-1745 | 21 | 72% | 20 |
Classes with closest relation at Level 1 |